Beaconsfield, Canada

Robert Zamboni

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Cosmas Therapeutics Development Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Zamboni. Retrieved from https://idiyas.com/inventor/robert-zamboni-ay8d68zd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Robert Zamboni and Melatonin Receptor Research.

Introduction

Robert Zamboni is an inventor associated with Beaconsfield, Canada, and Cosmas Therapeutics Development Inc. His patent work concerns compounds that act on melatonin receptors and their potential pharmaceutical applications.

Latest Patents

Zamboni is named on 1 patent: “Modulators of the melatonin receptors as well as method of manufacture and uses thereof.” The invention describes compounds of formula (I), or pharmaceutically acceptable salts, that act as melatonin MT2 agonists, along with pharmaceutical compositions containing them. It also describes potential uses for managing or treating conditions associated with melatonin receptor activity, including pain, neuropsychiatric disorders, sleep and circadian rhythm disorders, hyperthermia, and metabolic disorders.

Career Highlights

Zamboni’s listed patent reflects work on the development and potential therapeutic use of melatonin receptor modulators. He is associated with Cosmas Therapeutics Development Inc.

Collaborations

The patent information also names Gabriella Gobbi and Shiguang Li as Zamboni’s coworkers. Their shared association with the patent points to collaboration in research and development related to melatonin receptor compounds.

Conclusion

Robert Zamboni’s patent work focuses on MT2 agonists and their possible applications across several health conditions, highlighting a contribution to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…